loadpatents
name:-0.0069479942321777
name:-0.0099530220031738
name:-0.0028829574584961
Berens; Michael E. Patent Filings

Berens; Michael E.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Berens; Michael E..The latest application filed is for "genetic signature of vulnerability to inhibitors of base excision repair (ber) in cancer".

Company Profile
1.8.4
  • Berens; Michael E. - Phoenix AZ
  • Berens; Michael E. - Gilbert AZ
  • Berens; Michael E. - Gillbert AZ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Genetic signature of vulnerability to inhibitors of base excision repair (BER) in cancer
Grant 10,227,659 - Mehta , et al.
2019-03-12
Genetic Signature Of Vulnerability To Inhibitors Of Base Excision Repair (ber) In Cancer
App 20170204472 - Mehta; Shwetal V. ;   et al.
2017-07-20
Genetic signature of vulnerability to inhibitors of base excision repair (BER) in cancer
Grant 9,637,798 - Mehta , et al. May 2, 2
2017-05-02
Genetic Signature Of Vulnerability To Inhibitors Of Base Excision Repair (ber) In Cancer
App 20160102360 - Mehta; Shwetal V. ;   et al.
2016-04-14
Methods and kits to identify invasive glioblastoma
Grant 8,962,581 - Kislin , et al. February 24, 2
2015-02-24
Cell migration inhibiting compositions and methods and compositions for treating cancer
Grant 7,700,615 - Edwards , et al. April 20, 2
2010-04-20
Polyamine Analogs as Modulators of Cell Migration and Cell Motility
App 20090143456 - Marton; Laurence J. ;   et al.
2009-06-04
Cell migration inhibiting compositions and methods and compositions for treating cancer
App 20060128742 - Edwards; David L. ;   et al.
2006-06-15
Cell migration inhibiting compositions and methods and compositions for treating cancer
Grant 7,012,100 - Edwards , et al. March 14, 2
2006-03-14
Guided cell sedimentation for biological studies
Grant 5,998,160 - Berens December 7, 1
1999-12-07
Induction of immune tolerance to tumor cells
Grant 5,723,718 - Berens March 3, 1
1998-03-03
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed